Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(29%)
Results Posted
33%(1 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_4
1
14%
Ph not_applicable
1
14%
Ph phase_2
3
43%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (60.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

completed343%
not_yet_recruiting114%
terminated114%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7